|
1
|
Turunen MJ and Peltokallio P: Delay in the
diagnosis of colorectal cancer. Ann Chir Gynaecol. 71:277–282.
1982.PubMed/NCBI
|
|
2
|
Keighley MR, O’Morain C, Giacosa A, Ashorn
M, Burroughs A, Crespi M, Delvaux M, Faivre J, Hagenmuller F, Lamy
V, et al; United European Gastroenterology Federation Public
Affairs Committee. Public awareness of risk factors and screening
for colorectal cancer in Europe. Eur J Cancer Prev. 13:257–262.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
John SK, George S, Primrose JN and Fozard
JB: Symptoms and signs in patients with colorectal cancer.
Colorectal Dis. 13:17–25. 2011. View Article : Google Scholar
|
|
4
|
McColl KE: Clinical practice.
Helicobacter pylori infection. N Engl J Med. 362:1597–1604.
2010.PubMed/NCBI
|
|
5
|
Malfertheiner P, Megraud F, O’Morain CA,
Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY,
Rokkas T, et al; European Helicobacter Study Group. Management of
Helicobacter pylori infection - the Maastricht IV/Florence
Consensus Report. Gut. 61:646–664. 2012.
|
|
6
|
Rehnberg-Laiho L, Rautelin H, Koskela P,
Sarna S, Pukkala E, Aromaa A, Knekt P and Kosunen TU: Decreasing
prevalence of helicobacter antibodies in Finland, with reference to
the decreasing incidence of gastric cancer. Epidemiol Infect.
126:37–42. 2001.
|
|
7
|
Malaty HM: Epidemiology of Helicobacter
pylori infection. Best Pract Res Clin Gastroenterol.
21:205–214. 2007.
|
|
8
|
Kosunen TU, Aromaa A, Knekt P, Salomaa A,
Rautelin H, Lohi P and Heinonen OP: Helicobacter antibodies in 1973
and 1994 in the adult population of Vammala, Finland. Epidemiol
Infect. 119:29–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rautelin H and Kosunen TU: Helicobacter
pylori infection in Finland. Ann Med. 36:82–88. 2004.
View Article : Google Scholar
|
|
10
|
No authors listed. Schistosomes, liver
flukes and Helicobacter pylori. In: IARC Working Group on
the Evaluation of Carcinogenic Risks to Humans; Lyon. 7–14 June
1994; IARC Monogr Eval Carcinog Risks Hum. 61. pp. 1–241. 1994
|
|
11
|
Collins D, Hogan AM and Winter DC:
Microbial and viral pathogens in colorectal cancer. Lancet Oncol.
12:504–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buso AG, Rocha HL, Diogo DM, Diogo PM and
Diogo-Filho A: Seroprevalence of Helicobacter pylori in
patients with colon adenomas in a Brazilian university hospital.
Arq Gastroenterol. 46:97–101. 2009.
|
|
13
|
Burnett-Hartman AN, Newcomb PA and Potter
JD: Infectious agents and colorectal cancer: a review of
Helicobacter pylori, Streptococcus bovis, JC virus,
and human papillomavirus. Cancer Epidemiol Biomarkers Prev.
17:2970–2979. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Machida-Montani A, Sasazuki S, Inoue M,
Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T and Tsugane
S: Atrophic gastritis, Helicobacter pylori, and colorectal
cancer risk: a case-control study. Helicobacter. 12:328–332.
2007.
|
|
15
|
Inoue I, Mukoubayashi C, Yoshimura N, Niwa
T, Deguchi H, Watanabe M, Enomoto S, Maekita T, Ueda K, Iguchi M,
et al: Elevated risk of colorectal adenoma with Helicobacter
pylori-related chronic gastritis: a population-based
case-control study. Int J Cancer. 129:2704–2711. 2011.PubMed/NCBI
|
|
16
|
Osterlund P, Ruotsalainen T, Korpela R,
Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I and Joensuu H:
Lactobacillus supplementation for diarrhoea related to chemotherapy
of colorectal cancer: a randomised study. Br J Cancer.
97:1028–1034. 2007. View Article : Google Scholar
|
|
17
|
No authors listed. Preoperative short-term
radiation therapy in operable rectal carcinoma. A prospective
randomized trial. Stockholm Rectal Cancer Study Group. Cancer.
66:49–55. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oksanen A, Veijola L, Sipponen P, Schauman
KO and Rautelin H: Evaluation of Pyloriset Screen, a rapid
whole-blood diagnostic test for Helicobacter pylori
infection. J Clin Microbiol. 36:955–957. 1998.PubMed/NCBI
|
|
19
|
Houghton J and Wang TC: Helicobacter
pylori and gastric cancer: a new paradigm for
inflammation-associated epithelial cancers. Gastroenterology.
128:1567–1578. 2005. View Article : Google Scholar
|
|
20
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
21
|
Lan L, Yu J, Chen YL, Zhong YL, Zhang H,
Jia CH, Yuan Y and Liu BW: Symptom-based tendencies of
Helicobacter pylori eradication in patients with functional
dyspepsia. World J Gastroenterol. 17:3242–3247. 2011.PubMed/NCBI
|
|
22
|
O’Reilly D and Long RG: Carcinoma of the
colon presenting with dyspepsia. Postgrad Med J. 63:215–216.
1987.
|
|
23
|
Kosunen TU, Pukkala E, Sarna S and
Rautelin H: Eradication therapy and subsequent gastric and other
common malignancies. Helicobacter. 15:327(Abstract). 2010.
|
|
24
|
Lomer MC, Parkes GC and Sanderson JD:
Review article: lactose intolerance in clinical practice - myths
and realities. Aliment Pharmacol Ther. 27:93–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang SY, Han JH, Ahn MS, Lee HW, Jeong SH,
Park JS, Cho YK, Han SU, Kim YB, Kim JH, et al: Helicobacter
pylori infection as an independent prognostic factor for
locally advanced gastric cancer patients treated with adjuvant
chemotherapy after curative resection. Int J Cancer. 130:948–958.
2012. View Article : Google Scholar
|
|
26
|
Marrelli D, Pedrazzani C, Berardi A, Corso
G, Neri A, Garosi L, Vindigni C, Santucci A, Figura N and Roviello
F: Negative Helicobacter pylori status is associated with
poor prognosis in patients with gastric cancer. Cancer.
115:2071–2080. 2009.PubMed/NCBI
|
